Letermovir Shows Efficacy Preventing Cytomegalovirus Disease in Adults After Kidney Transplantation
October 26th 2022The objective of the trial was to compare letermovir with valganciclovir in preventing CMV disease in adults who received a kidney transplant and who are at high risk for CMV disease.
Read More